() fell below its 50 day moving average on Wednesday during trading. Stock has a moving average of GBX 26,50 ($0.33), and traded as low GBX 26, ($0.32). Mereo BioPharma Group plc shares (MPH.L), with a trading volume of 49.264 shares, were last seen at GBX 26,50 ($0.33).
Mereo BioPharma Group plc MPH.L Trading down 1.9 %
The market cap is PS89.76m and the P/E ratio is -0.21. The company's current ratio is 2.98. Its quick ratio is 2.92. And its debt-to equity ratio is 164.26. The stock's 50-day moving average is GBX 26,50, and its 200-day moving average is GBX 26,50.
Mereo BioPharma Group plc MPH.L Company Profile
Mereo BioPharma Group plc is a biopharmaceutical firm that acquires, develops and commercializes therapeutics to treat oncology and other rare diseases. Its lead product, etigilimab, an antibody T cell immunoreceptor with Ig domains and ITIM, is currently in Phase 1b of a clinical trial to treat tumors.
MarketBeat.com offers a FREE daily email newsletter